ロード中...
Synergistic effect of a novel autophagy inhibitor and Quizartinib enhances cancer cell death
Drug combinations have been increasingly applied in chemotherapy as a strategy to enhance the efficacy of anti-cancer treatment. The appropriate drug combinations may achieve synergistic effects beyond monotherapies alone. AC220 (Quizartinib), an FLT3 receptor tyrosine kinase inhibitor, developed fo...
保存先:
| 出版年: | Cell Death Dis |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5833862/ https://ncbi.nlm.nih.gov/pubmed/29374185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-017-0170-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|